Drug intelligence / Profile preview

povidone-iodine + bupivacaine + isopropyl alcohol + dexamethasone

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Topical, Local Infiltration, Perioperative Wound Irrigation
01

Overview

This is a **combination drug product** containing four active ingredients: povidone-iodine, bupivacaine, isopropyl alcohol, and dexamethasone. - **Povidone-iodine** is a topical antiseptic with broad-spectrum antimicrobial activity, commonly used to prevent or treat infection in wounds and as a surgical antiseptic[12][2][5]. Its mechanism is the slow release of free iodine, which penetrates microbial cell walls, oxidizing cell components and disrupting protein and nucleic acid structure, leading to cell death. - **Bupivacaine** is a long-acting amide-type local anesthetic used for local or regional anesthesia and analgesia in surgical procedures[1]. Its primary mechanism is the blockade of voltage-gated sodium channels in neuronal membranes, inhibiting initiation and propagation of nerve impulses and thus causing loss of sensation[1]. Additional effects may arise from prostaglandin E2 receptor subtype EP1 (PGE2EP1) binding, contributing to anti-inflammatory and analgesic actions. - **Isopropyl alcohol** is a rapidly acting topical antiseptic and disinfectant used pre-operatively for skin antisepsis. It denatures proteins and disrupts cell membranes, leading to rapid microbial cell death. It is widely used for its bactericidal and virucidal properties. - **Dexamethasone** is a potent synthetic glucocorticoid with anti-inflammatory, immunosuppressive, and antiemetic effects[6][3][11]. Mechanistically, it binds cytoplasmic glucocorticoid receptors, altering transcription of anti-inflammatory proteins and suppressing production of pro-inflammatory cytokines. This combination may be used in perioperative or procedural settings, especially where prevention of infection and management of pain and inflammation are required. No unique FDA-approved combination product with this exact set of ingredients was identified; the combination may be used in compounded formulations for specific surgical protocols (e.g., in kits for local infiltration or as part of perioperative wound management strategies)[7][10].

Brand names
Pain Management KitArthro-PakSurgical Prep Kit
Other names
Bupivacaine and Dexamethasone Injection KitBupivacaine-Dexamethasone-Iodine-Alcohol Kit
02

Targets

NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)PTGER1 (Prostaglandin E Receptor 1)

Beyond the preview

Go deeper on povidone-iodine + bupivacaine + isopropyl alcohol + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on povidone-iodine + bupivacaine + isopropyl alcohol + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call